Reply to letter to the editor: "adenosine di-phosphate receptor antagonist discontinuation management prior to coronary artery surgery".
Divisione di Cardiologia 1-Emodinamica, Dipartimento Cardio-toraco-vascolare "A. De Gasperis", Azienda Ospedaliera Ospedale Niguarda Cà Granda, Milan, Italy. Electronic address: nuccia.morici@ospedaleniguarda.it.
Nuccia
N
Morici
Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Milan, Italy; IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.
Lorenzo
L
Moja
Dipartimento di Epidemiologia, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Valentina
V
Rosato
Divisione di Cardiologia, IRCCS Arcispedale S. Maria Nuova, Reggio Emilia, Italy.
Stefano
S
Savonitto
D054058:Acute Coronary Syndrome / Q000628:therapy*; D001026:Coronary Artery Bypass / Q000379:methods*; D006801:Humans; D058921:Purinergic P2Y Receptor Antagonists / Q000008:administration & dosage*; D028761:Withholding Treatment
D058921:Purinergic P2Y Receptor Antagonists
Acute coronary syndrome; Antiplatelet; Coronary surgery